After Alzheimer’s disease, Parkinson’s disease is currently the second most common neurodegenerative disease. The majority of those affected are ≥60 years old when it first manifests, but a minority develop the disease at a younger age. With suitable symptomatic therapies, the disease can often be well controlled for years. Consideration of the individual symptom profile is crucial here. A causal therapy does not yet exist, but disease-modifying approaches are being researched.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Case report: Drug-induced hepatitis
Rare side effect of tirzepatide therapy
- Plea for sex-specific neurology
Migraine in men: underdiagnosed, underestimated, under-researched
- Prurigo nodularis
Retrospective analyses of large data sets from everyday practice
- Public Health
Outpatient care in Switzerland: situation report
- Practice Management
Improved quality of care aims for satisfied patients
- Chemsex - MSM, sex, chrystal meth & co.
Medical and psychosocial perspectives
- Bladder cancer
Tuberculosis vaccination reduces recurrences
- Oral JAK-i in atopic dermatitis